106 related articles for article (PubMed ID: 33183172)
1. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract][Full Text] [Related]
2. Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.
Nadolny C; Dong X
Cancer Biol Ther; 2015; 16(7):997-1004. PubMed ID: 25951367
[TBL] [Abstract][Full Text] [Related]
3. In silico optimization of peptides that inhibit Wnt/β-catenin signaling.
Fujita M; Tsuchiya K; Kurohara T; Fukuhara K; Misawa T; Demizu Y
Bioorg Med Chem; 2023 Apr; 84():117264. PubMed ID: 37003158
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.
Li C; Dong J; Han Z; Zhang K
Oncol Res; 2017 Apr; 25(4):617-627. PubMed ID: 27983934
[TBL] [Abstract][Full Text] [Related]
6. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
7. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of coactivation of liver receptor homolog-1 by β-catenin.
Yumoto F; Nguyen P; Sablin EP; Baxter JD; Webb P; Fletterick RJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):143-8. PubMed ID: 22187462
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation.
Benod C; Vinogradova MV; Jouravel N; Kim GE; Fletterick RJ; Sablin EP
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):16927-31. PubMed ID: 21949357
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
11. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery of antagonists of nuclear receptor LRH-1.
Benod C; Carlsson J; Uthayaruban R; Hwang P; Irwin JJ; Doak AK; Shoichet BK; Sablin EP; Fletterick RJ
J Biol Chem; 2013 Jul; 288(27):19830-44. PubMed ID: 23667258
[TBL] [Abstract][Full Text] [Related]
13. HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway.
Gao Y; Fei X; Kong L; Tan X
Anticancer Drugs; 2020 Sep; 31(8):828-835. PubMed ID: 32796404
[TBL] [Abstract][Full Text] [Related]
14. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
15. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
16. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
[TBL] [Abstract][Full Text] [Related]
17. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.
Maftouh M; Belo AI; Avan A; Funel N; Peters GJ; Giovannetti E; Van Die I
Oncotarget; 2014 Jul; 5(14):5335-49. PubMed ID: 24977327
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis.
Hu B; Qiu-Lan H; Lei RE; Shi C; Jiang HX; Qin SY
Biomed Res Int; 2017; 2017():2831056. PubMed ID: 28349057
[No Abstract] [Full Text] [Related]
19. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
Froeling FE; Feig C; Chelala C; Dobson R; Mein CE; Tuveson DA; Clevers H; Hart IR; Kocher HM
Gastroenterology; 2011 Oct; 141(4):1486-97, 1497.e1-14. PubMed ID: 21704588
[TBL] [Abstract][Full Text] [Related]
20. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
